Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.
The research is looking into patients’ experiences of radiotherapy treatment for gynaecological cancers with the aim to: increase understanding of how radiotherapy impacts on social, personal and sexual lives and longer-term post-treatment experiences of gynaecological cancer explore the experiences of those who are/have been carers or sign…
The aim of the trial is to fully understand the benefits of a PARP inhibitor versus standard chemotherapy for BRCA-positive women who have had two previous treatments. Drugs involved in this trial: rucaparib, a PARP inhibitor paclitaxel, a standard chemotherapy drug carboplatin or cisplatin, standard chemotherapy drugs. Women in t…
The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…
This study is looking at using a new drug called TAK228 (new drug) in combination with paclitaxel (a chemotherapy drug) to see if it is a more effective way of treating ovarian cancer. If you were to take part in this trial you would be randomised to receive either paclitaxel on its own or paclitaxel and TAK228. You would be monitored throughout…
This study collects information about people who have inherited faulty cancer genes. Inheriting a faulty gene means that a person is at a higher risk of developing certain cancers. A fault in the BRCA1 or BRCA2 genes means that a person is more likely to develop cancers of the breast, ovary or prostate. As well as the BRCA1 and BRCA2 genes, we n…
Around half of women diagnosed with ovarian cancer are over the age of 65. Older women may have different medical and social problems than those seen in younger women. This may result in them being offered less intensive chemotherapy options to treat their ovarian cancer. Research has already shown that in older people who don’t have cancer, und…
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
